Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AXSM exchanges : Nyse save search
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Dollar General Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DG
Published: 2023-12-25 (Crawled : 16:00) - prnewswire.com
BCS | $9.6 -1.03% 5.73% 19M
|
Finance
| Email alert
Add to watchlist
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
| Email alert
Add to watchlist
BCLYF | $2.28 -1.3% -10.14% 0
|
Finance
| Email alert
Add to watchlist
DG 4 | $143.16 0.3% 0.54% 1M
|
Retail Trade
| Email alert
Add to watchlist
corporation deadline global
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Barclays PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCS, BCLYF
Published: 2023-11-27 (Crawled : 01:00) - prnewswire.com
BCLYF | $2.28 -1.3% -10.14% 0
|
Finance
|
| O: 0.0%
H: 0.28%
C: -1.97%
BCS | $9.6 -1.03% 5.73% 19M
|
Finance
|
| O: -0.69%
H: 0.42%
C: -0.42%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: 0.1%
H: 5.89%
C: 5.83%
AHCO | $9.78 -0.31% -0.31% 520K
|
Finance
|
| O: 0.35%
H: 2.37%
C: 1.16%
deadline
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose
Published: 2023-10-31 (Crawled : 23:00) - biospace.com/
CYBN | $0.355 0.0% 7.8K
|
n/a
|
| O: 11.35%
H: 9.32%
C: -4.16%
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: 0.0%
H: 3.76%
C: 3.75%
cyb003 rapid positive depression meeting
Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors
Published: 2023-10-11 (Crawled : 11:00) - globenewswire.com
ZYME | $8.55 -0.12% -0.06% 240K
|
Health Technology
|
| O: -0.16%
H: 0.93%
C: 0.85%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 4.47%
H: 2.11%
C: 1.52%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: -0.11%
H: 1.04%
C: -0.41%
therapeutics
Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period (2019-2032), Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo
Published: 2023-10-04 (Crawled : 21:00) - prnewswire.com
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: 0.0%
RVMD | $35.59 -1.85% -1.97% 1.3M
|
Health Technology
|
| O: -0.58%
H: 4.83%
C: 4.38%
IOVA 4 | $11.71 -1.27% -1.45% 1.6K
|
Health Technology
|
| O: 0.24%
H: 3.66%
C: 1.95%
BNTX | News | $88.09 -0.45% -0.35% 1.9K
|
Health Technology
|
| O: -0.44%
H: 1.52%
C: 0.08%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: -0.43%
H: 4.97%
C: 4.71%
lung companies cancer study market
Narcolepsy Market Analysis, Market Size, Epidemiology, and Competitive Analysis of Leading Companies Including Takeda, Suven Life Sciences Limited, Axsome Therapeutics, Inc., Avadel, and Others by DelveInsight
Published: 2023-10-03 (Crawled : 21:00) - prnewswire.com
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: -2.39%
H: 0.0%
C: 0.0%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: -0.66%
H: 2.5%
C: 1.89%
ACAD | News | $16.59 -0.9% -1.03% 1.3M
|
Health Technology
|
| O: -0.82%
H: 5.05%
C: 4.42%
companies life narcolepsy sciences market
Axsome Therapeutics to Present at Three Upcoming Investor Conferences
Published: 2023-09-05 (Crawled : 11:00) - globenewswire.com
MS | News 0 d | $93.85 0.1% -0.02% 3.3M
|
Finance
|
| O: 0.01%
H: 0.0%
C: 0.0%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: -0.43%
H: 0.72%
C: -2.96%
therapeutics
Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and Company, Janssen, Merck, BioVie, Biogen, Vivoryon, Sage, Alnylam, BioXcel, EIP, Otsuka, Alector, Transposon
Published: 2023-07-26 (Crawled : 21:00) - prnewswire.com
COYA | News | $8.41 4.86% 3.14% 120K
|
|
| O: 0.0%
H: 1.87%
C: 0.5%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: -0.06%
H: 1.18%
C: 0.37%
SEEL | $0.301 -7.98% -10.1% 600K
|
Health Technology
|
| O: 1.48%
H: 0.73%
C: -2.19%
PRTA 4 | $20.56 0.15% 340K
|
Health Technology
|
| O: 1.08%
H: 2.08%
C: 1.79%
PASG | News | $1.24 0.81% 3.15% 39K
|
Health Technology
|
| O: 3.33%
H: 0.0%
C: -8.82%
IONS | $42.45 1.46% 1.45% 730K
|
Health Technology
|
| O: 0.33%
H: 0.13%
C: -1.56%
DNLI | $15.56 -3.41% -3.6% 40
|
Health Technology
|
| O: 1.22%
H: 0.0%
C: -1.42%
SAVA M | $20.74 0.93% 0.96% 450K
|
Health Technology
|
| O: 0.6%
H: 1.74%
C: 1.24%
BIVI | $0.5054 2.77% 2.13% 190K
|
Health Technology
|
| O: 0.43%
H: 0.85%
C: -2.12%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: 0.56%
H: 3.6%
C: 0.99%
companies active dementia market
Axsome Therapeutics Enters into License Agreement with Pharmanovia to Expand Commercialization and Further Develop Sunosi® (solriamfetol) in Europe
Published: 2023-02-22 (Crawled : 13:00) - biospace.com/
MS | News 0 d | $93.85 0.1% -0.02% 3.3M
|
Finance
|
| O: -0.26%
H: 0.72%
C: -0.1%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: 1.21%
H: 1.23%
C: -2.52%
sunosi europe commercialization license therapeutics agreement solriamfetol
Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in Neuroscience
Published: 2022-03-28 (Crawled : 12:00) - biospace.com/
HTGC 4 | $18.96 0.58% 2.0% 1.8K
|
Finance
|
| O: -0.11%
H: 0.05%
C: -0.6%
JAZZ | $108.32 -1.23% -1.19% 400K
|
Health Technology
|
| O: 0.42%
H: 0.14%
C: -2.0%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: 3.14%
H: 7.73%
C: -3.73%
sunosi therapeutics
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-08 (Crawled : 12:15) - globenewswire.com
HTGC 4 | $18.96 0.58% 2.0% 1.8K
|
Finance
|
| O: -0.11%
H: 0.0%
C: 0.0%
AXSM | $71.17 -2.61% -2.6% 14
|
Health Technology
|
| O: -1.44%
H: 12.29%
C: 8.6%
financial results results
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.